Retatrutide

Retatrutide Injectable for Sale

Disclaimer: All LM Peptides products are only intended for laboratory research use and are not approved for human consumption.

Overview of Retatrutide

Retatrutide is a synthetic research peptide that is studied for its role in metabolic and endocrine investigations. It acts as a triple agonist to activate three key hormone receptors that are responsible for energy balance and metabolic regulation in test models. Researchers study its potential roles in weight regulation, metabolic signaling, and liver function in research models. 

Retatrutide is studied for how it affects appetite signaling, energy expenditure, and metabolic pathways in research. These pathways play key roles in appetite cues and fat metabolism in research models. Its triple-receptor profile allows researchers to note Retatrutide’s combined effects across several metabolic systems in a research environment.

Section Details

CAS Number

2381089-83-2 [R]

Molar Mass

4731 g/mol

Chemical Formula

C221H342N46O68

Synonyms

Retatrutide, orb1981169, EX-A7826E, GTPL13769, LY3437943

Ingredients / Composition

Retatrutide injectable contains Retatrutide as a key ingredient, which is tested at 98.9% purity.

Shelf Life

2 years

Storage Instructions

Store Retatrutide injectable at 2 to 8°C.

Disclaimer

Retatrutide is not approved for human use. It is available for research purposes only.

Frequently Asked Questions

Retatrutide is not approved by the FDA for human consumption in the United States. It is legally available only for research purposes at this time.

Retatrutide reduces appetite and increases energy expenditure by activating its three target receptors (GLP‑1, GIP, and glucagon) in research models. This triple‑agonist action contributes to weight loss in research models. It improves glucose tolerance and insulin sensitivity in test models and also suggests benefits for metabolic regulation.

The pharmacokinetics of Retatrutide show a half‑life of about 6 days, which supports a once‑weekly dosing regimen in research models. The metabolic effects are observed within 24–72 hours after administration in research models. 

Retatrutide is generally considered safe in controlled conditions. The observed unwanted effects are mild and related to the digestive system in research models. Some studies also report temporary increases in heart rate in test models. 

The delivery of Retatrutide Injectables takes 5 to 12 business days. It depends on the shipping method and the destination where this product needs to be delivered.

Researchers recommend many online peptide suppliers, but Iron Mountain Labz stands out for its product testing and verified purity. Peptide products are available in multiple formats, such as peptide kits, nasal sprays, and single vials for research purposes.